Welcome to PracticeUpdate! We hope you are enjoying temporary access to this content.
Please register today for a free account and gain full access
to all of our expert-selected content.
Already Have An Account? Log in Now
Opioid vs Opioid-Free Analgesia After Surgical Discharge
abstract
This abstract is available on the publisher's site.
Access this abstract now Full Text Available for ClinicalKey SubscribersBACKGROUND
Excessive opioid prescribing after surgery has contributed to the current opioid crisis; however, the value of prescribing opioids at surgical discharge remains uncertain. We aimed to estimate the extent to which opioid prescribing after discharge affects self-reported pain intensity and adverse events in comparison with an opioid-free analgesic regimen.
METHODS
In this systematic review and meta-analysis, we searched MEDLINE, Embase, the Cochrane Library, Scopus, AMED, Biosis, and CINAHL from Jan 1, 1990, until July 8, 2021. We included multidose randomised controlled trials comparing opioid versus opioid-free analgesia in patients aged 15 years or older, discharged after undergoing a surgical procedure according to the Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity definition (minor, moderate, major, and major complex). We screened articles, extracted data, and assessed risk of bias (Cochrane's risk-of-bias tool for randomised trials) in duplicate. The primary outcomes of interest were self-reported pain intensity on day 1 after discharge (standardised to 0-10 cm visual analogue scale) and vomiting up to 30 days. Pain intensity at further timepoints, pain interference, other adverse events, risk of dissatisfaction, and health-care reutilisation were also assessed. We did random-effects meta-analyses and appraised evidence certainty using the Grading of Recommendations, Assessment, Development, and Evaluations scoring system. The review was registered with PROSPERO (ID CRD42020153050).
FINDINGS
47 trials (n=6607 patients) were included. 30 (64%) trials involved elective minor procedures (63% dental procedures) and 17 (36%) trials involved procedures of moderate extent (47% orthopaedic and 29% general surgery procedures). Compared with opioid-free analgesia, opioid prescribing did not reduce pain on the first day after discharge (weighted mean difference 0·01cm, 95% CI -0·26 to 0·27; moderate certainty) or at other postoperative timepoints (moderate-to-very-low certainty). Opioid prescribing was associated with increased risk of vomiting (relative risk 4·50, 95% CI 1·93 to 10·51; high certainty) and other adverse events, including nausea, constipation, dizziness, and drowsiness (high-to-moderate certainty). Opioids did not affect other outcomes.
INTERPRETATION
Findings from this meta-analysis support that opioid prescribing at surgical discharge does not reduce pain intensity but does increase adverse events. Evidence relied on trials focused on elective surgeries of minor and moderate extent, suggesting that clinicians can consider prescribing opioid-free analgesia in these surgical settings. Data were largely derived from low-quality trials, and none involved patients having major or major-complex procedures. Given these limitations, there is a great need to advance the quality and scope of research in this field.
FUNDING
The Canadian Institutes of Health Research.
Additional Info
Disclosure statements are available on the authors' profiles:
Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis of randomised trials
Lancet 2022 Jun 18;399(10343)2280-2293, JF Fiore, C El-Kefraoui, MA Chay, P Nguyen-Powanda, U Do, G Olleik, F Rajabiyazdi, A Kouyoumdjian, A Derksen, T Landry, A Amar-Zifkin, A Bergeron, AV Ramanakumar, M Martel, L Lee, G Baldini, LS FeldmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Key Points
Opioid prescribing at surgical discharge for minor and moderate surgeries does not reduce pain intensity; however, it does increase adverse events. In the accompanying editorial1 the authors noted, "opioids after discharge should be reserved only for people recovering from major surgery, and this prescription should incorporate an opioid-tapering strategy."
Relevance
Although opioid prescribing patterns have begun to change, opioids continue to be routinely prescribed for even minor surgeries where their benefit-to-harm ratio may place patients at risk of increased adverse effects
Comments
The results of this recent analysis by a multidisciplinary team including members of the Department of Surgery at McGill University remind me of similar eye-opening results of the SPACE trial from the VA in 2018, which demonstrated that opioid analgesics did not have significant benefits beyond well-planned nonopioid pain care while also increasing adverse effects.
In this case, we have similar findings that challenge long-standing prescription patterns which typically dictate that discharge–no matter the type of surgery–require some type of opiate prescription.
The unfortunate departure from previous chronic pain management trials comes on the journey home from surgery. While we have an increasing number and comfort with recommending interventions such as those noted in the American College of Physicians guidelines, the toolbox home from surgery is much emptier. Even when there is research evidence, there is much less availability and comfort in knowing how to fully support our patients going home, especially with nonpharmacological, behavioral, and physical therapies in the already fragile post-op scenario.
However, this review shows us that in some ways we are making that fragile scenario even more problematic by providing an opioid prescription in more cases than not. Hopefully, it will draw more attention to efforts such as that by Stanford’s Dr. Beth Darnall whose My Surgical Success is using presurgical behavioral care to reduce post-op pain, anxiety, and medication requirement.2 Certainly, this approach needs to be individualized especially for patients who are on chronic opioids and for many others. This study will hopefully initiate expansive clinical trials of what a practical and accessible nonopioid discharge toolbox should look like so that patients and care teams can carefully begin to have practical options that will help translate this research into clinical practice.
Details
In total, 47 trials (N = 6607 participants), which examined prescriptions after minor surgeries (predominately dental and hand surgery) and moderate surgeries (eg, minimally invasive orthopedic or general surgery), were included. This study did not look at major surgeries (ie, bowel, liver, and lung resections).
References